These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16478727)

  • 1. Unique substrate recognition by botulinum neurotoxins serotypes A and E.
    Chen S; Barbieri JT
    J Biol Chem; 2006 Apr; 281(16):10906-11. PubMed ID: 16478727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple pocket recognition of SNAP25 by botulinum neurotoxin serotype E.
    Chen S; Barbieri JT
    J Biol Chem; 2007 Aug; 282(35):25540-7. PubMed ID: 17609207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of substrate recognition by botulinum neurotoxin serotype A.
    Chen S; Kim JP; Barbieri JT
    J Biol Chem; 2007 Mar; 282(13):9621-9627. PubMed ID: 17244603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin.
    Chen S; Hall C; Barbieri JT
    J Biol Chem; 2008 Jul; 283(30):21153-9. PubMed ID: 18511417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycine insertion at protease cleavage site of SNAP25 resists cleavage but enhances affinity for botulinum neurotoxin serotype A.
    Ho M; Goh CH; Brothers MC; Wang S; Young RL; Ou Y; Lui JN; Kalafatis M; Lan X; Wolf AE; Rienstra CM; Wilson BA
    Protein Sci; 2012 Mar; 21(3):318-26. PubMed ID: 22170566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
    Arndt JW; Chai Q; Christian T; Stevens RC
    Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNAP-25 substrate peptide (residues 180-183) binds to but bypasses cleavage by catalytically active Clostridium botulinum neurotoxin E.
    Agarwal R; Swaminathan S
    J Biol Chem; 2008 Sep; 283(38):25944-51. PubMed ID: 18658150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic properties of botulinum neurotoxin subtypes A3 and A4.
    Henkel JS; Jacobson M; Tepp W; Pier C; Johnson EA; Barbieri JT
    Biochemistry; 2009 Mar; 48(11):2522-8. PubMed ID: 19256469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and biochemical characterization of the protease domain of the mosaic botulinum neurotoxin type HA.
    Lam KH; Sikorra S; Weisemann J; Maatsch H; Perry K; Rummel A; Binz T; Jin R
    Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29688327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of botulinum neurotoxin serotype A light chain with plasma membrane-bound SNAP-25.
    Chen S; Barbieri JT
    J Biol Chem; 2011 Apr; 286(17):15067-72. PubMed ID: 21378164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity.
    Jin R; Sikorra S; Stegmann CM; Pich A; Binz T; Brunger AT
    Biochemistry; 2007 Sep; 46(37):10685-93. PubMed ID: 17718519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of substrate recognition by the novel Botulinum Neurotoxin subtype F5.
    Guo J; Chan EW; Chen S
    Sci Rep; 2016 Jan; 6():19875. PubMed ID: 26794648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
    Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
    J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubility of the catalytic domains of Botulinum neurotoxin serotype E subtypes.
    Chen S; Barbieri JT
    Protein Expr Purif; 2016 Feb; 118():18-24. PubMed ID: 26477500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of substrate recognition and specificity of botulinum neurotoxin serotype F.
    Chen S; Wan HY
    Biochem J; 2011 Jan; 433(2):277-84. PubMed ID: 21029044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition.
    Arndt JW; Yu W; Bi F; Stevens RC
    Biochemistry; 2005 Jul; 44(28):9574-80. PubMed ID: 16008342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum neurotoxin types A and E require the SNARE motif in SNAP-25 for proteolysis.
    Washbourne P; Pellizzari R; Baldini G; Wilson MC; Montecucco C
    FEBS Lett; 1997 Nov; 418(1-2):1-5. PubMed ID: 9414082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characterisation of the catalytic domain of botulinum neurotoxin X - high activity and unique substrate specificity.
    Masuyer G; Zhang S; Barkho S; Shen Y; Henriksson L; Košenina S; Dong M; Stenmark P
    Sci Rep; 2018 Mar; 8(1):4518. PubMed ID: 29540745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5.
    Wang D; Krilich J; Pellett S; Baudys J; Tepp WH; Barr JR; Johnson EA; Kalb SR
    Biochim Biophys Acta; 2013 Dec; 1834(12):2722-8. PubMed ID: 24096023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a recombinant fluorescent substrate with cleavage sites for all botulinum neurotoxins in high-throughput screening of natural product extracts for inhibitors of serotypes A, B, and E.
    Hines HB; Kim AD; Stafford RG; Badie SS; Brueggeman EE; Newman DJ; Schmidt JJ
    Appl Environ Microbiol; 2008 Feb; 74(3):653-9. PubMed ID: 18083881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.